NexoBrid
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Thermal Burns
Conditions
Thermal Burns
Trial Timeline
May 1, 2015 → Dec 1, 2022
NCT ID
NCT02278718About NexoBrid
NexoBrid is a phase 3 stage product being developed by MediWound for Thermal Burns. The current trial status is completed. This product is registered under clinical trial identifier NCT02278718. Target conditions include Thermal Burns.
What happened to similar drugs?
0 of 1 similar drugs in Thermal Burns were approved
Approved (0) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04040660 | Pre-clinical | Completed |
| NCT02278718 | Phase 3 | Completed |
Competing Products
4 competing products in Thermal Burns
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| R475 + Placebo | Sanofi | Phase 2 | 27 |
| cP12 | United Therapeutics | Phase 2 | 39 |
| NexoBrid | MediWound | Pre-clinical | 16 |
| NexoBrid + Gel Vehicle | MediWound | Phase 3 | 30 |